On Monday, Inhibikase Therapeutics Inc (NASDAQ: IKT) was -3.49% drop from the session before settling in for the closing price of $1.72. A 52-week range for IKT has been $1.33 – $3.50.
Healthcare Sector giant saw their annual sales surged by 18.99% over the last five years. When this article was written, the company’s average yearly earnings per share was at 54.53%. With a float of $99.08 million, this company’s outstanding shares have now reached $121.27 million.
Inhibikase Therapeutics Inc (IKT) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Inhibikase Therapeutics Inc stocks. The insider ownership of Inhibikase Therapeutics Inc is 18.30%, while institutional ownership is 36.32%. The most recent insider transaction that took place on Nov 21 ’25, was worth 2,999,999. In this transaction 10% Owner of this company bought 2,068,965 shares at a rate of $1.45, taking the stock ownership to the 13,018,965 shares.
Inhibikase Therapeutics Inc (IKT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 54.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.95% during the next five years compared to 18.99% growth over the previous five years of trading.
Inhibikase Therapeutics Inc (NASDAQ: IKT) Trading Performance Indicators
You can see what Inhibikase Therapeutics Inc (IKT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 11.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.57, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of Inhibikase Therapeutics Inc (IKT)
Analysing the last 5-days average volume posted by the [Inhibikase Therapeutics Inc, IKT], we can find that recorded value of 0.8 million was better than the volume posted last year of 0.21 million. As of the previous 9 days, the stock’s Stochastic %D was 77.91%.
During the past 100 days, Inhibikase Therapeutics Inc’s (IKT) raw stochastic average was set at 57.89%, which indicates a significant decrease from 65.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1128 in the past 14 days, which was lower than the 0.1222 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5507, while its 200-day Moving Average is $1.7987. Now, the first resistance to watch is $1.7613. This is followed by the second major resistance level at $1.8627. The third major resistance level sits at $1.9308. If the price goes on to break the first support level at $1.5918, it is likely to go to the next support level at $1.5237. Now, if the price goes above the second support level, the third support stands at $1.4223.
Inhibikase Therapeutics Inc (NASDAQ: IKT) Key Stats
There are 75,175K outstanding shares of the company, which has a market capitalization of 201.30 million. As of now, sales total 0 K while income totals -27,520 K. Its latest quarter income was 0 K while its last quarter net income were -11,930 K.
